GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,645,000 | +422.1% | 450,000 | +165.6% | 0.17% | +503.6% |
| Q1 2022 | $5,870,000 | +131.9% | 169,458 | +96.0% | 0.03% | +115.4% |
| Q4 2021 | $2,531,000 | -92.3% | 86,454 | -85.6% | 0.01% | -94.3% |
| Q3 2020 | $33,084,000 | -44.5% | 600,000 | -20.0% | 0.23% | -43.0% |
| Q4 2019 | $59,618,000 | -23.8% | 750,000 | -53.5% | 0.40% | -32.0% |
| Q3 2019 | $78,218,000 | +32.2% | 1,612,069 | +43.3% | 0.59% | +53.5% |
| Q2 2019 | $59,175,000 | -25.5% | 1,125,000 | -25.0% | 0.38% | -35.5% |
| Q1 2019 | $79,395,000 | +33.4% | 1,500,000 | +3.4% | 0.60% | +36.9% |
| Q4 2018 | $59,523,000 | +14.3% | 1,450,000 | +5.8% | 0.44% | +41.6% |
| Q3 2018 | $52,060,000 | -2.8% | 1,370,000 | +15.6% | 0.31% | -6.9% |
| Q2 2018 | $53,562,000 | +300.3% | 1,185,000 | +248.5% | 0.33% | +203.7% |
| Q4 2017 | $13,379,000 | – | 340,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |